LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 21.94

Change

-0.27 (-1.22)%

Market Cap

CAD 0.23B

Volume

9.44K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.24 (+0.58%)

CAD 3.00B
ZWU:CA BMO Covered Call Utilities ETF

-0.02 (-0.18%)

CAD 1.96B
XIT:CA iShares S&P/TSX Capped Informa..

-0.38 (-0.63%)

CAD 0.67B
TXF:CA First Asset Tech Giants Covere..

-0.02 (-0.09%)

CAD 0.65B
XHC:CA iShares Global Healthcare (CAD..

-0.77 (-1.02%)

CAD 0.64B
HTA:CA Harvest Tech Achievers Growth ..

-0.04 (-0.21%)

CAD 0.64B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.03 (-0.11%)

CAD 0.56B
CWW:CA iShares Global Water Common Cl..

-0.25 (-0.41%)

CAD 0.34B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.04 (-0.14%)

CAD 0.33B
COW:CA iShares Global Agriculture Com..

-0.50 (-0.78%)

CAD 0.28B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.53% 20% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.53% 20% F 35% F
Trailing 12 Months  
Capital Gain 8.94% 14% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.94% 14% F 31% F
Trailing 5 Years  
Capital Gain 11.82% 17% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.82% 17% F 46% F
Average Annual (5 Year Horizon)  
Capital Gain 0.94% 17% F 39% F
Dividend Return 2.03% 9% A- 37% F
Total Return 1.10% 53% F 39% F
Risk Return Profile  
Volatility (Standard Deviation) 6.89% 97% N/A 82% B
Risk Adjusted Return 29.48% 26% F 48% F
Market Capitalization 0.23B 62% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.